SAMTASU

Serial Number 79278491
Registration 6219037
700

Registration Progress

Application Filed
Nov 20, 2019
Under Examination
Approved for Publication
Sep 29, 2020
Published for Opposition
Sep 29, 2020
Registered
Dec 15, 2020

Trademark Image

SAMTASU

Basic Information

Serial Number
79278491
Registration Number
6219037
Filing Date
November 20, 2019
Registration Date
December 15, 2020
Published for Opposition
September 29, 2020
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Dec 15, 2020
Registration
Registered
Classes
005

Rights Holder

Otsuka Pharmaceutical Co., Ltd.

03
Address
2-9 Kanda-Tsukasamachi
Chiyoda-ku
Tokyo 101-8535
JP

Ownership History

Otsuka Pharmaceutical Co., Ltd.

Original Applicant
03
Tokyo 101-8535 JP

Otsuka Pharmaceutical Co., Ltd.

Owner at Publication
03
Tokyo 101-8535 JP

Otsuka Pharmaceutical Co., Ltd.

Original Registrant
03
Tokyo 101-8535 JP

Legal Representation

Attorney
Marsha K. Hoover

USPTO Deadlines

Next Deadline
405 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2020-12-15)
Due Date
December 15, 2026
Grace Period Ends
June 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

26 events
Date Code Type Description Documents
Mar 12, 2023 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 4, 2021 FINV P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Mar 18, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Mar 18, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Mar 15, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Dec 15, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Sep 29, 2020 PUBO A PUBLISHED FOR OPPOSITION Loading...
Sep 29, 2020 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Sep 9, 2020 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Aug 23, 2020 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Aug 21, 2020 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Aug 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Aug 21, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Aug 19, 2020 ALIE A ASSIGNED TO LIE Loading...
Jul 31, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
May 8, 2020 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Apr 3, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Mar 16, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
Mar 16, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Feb 26, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
Feb 25, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Feb 25, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Feb 24, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Feb 20, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Feb 18, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Feb 13, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cardiovascular diseases; diuretics; pharmaceutical preparations for the treatment of hyponatremia; pharmaceutical preparations for the treatment of hyponatremia in patients with syndrome of inappropriate antidiuretic hormone (SIADH), heart failure, and cirrhosis; pharmaceutical preparations for the treatment of polycystic kidney diseases (PKD)
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Translation
The wording "SAMTASU" has no meaning in a foreign language.

Classification

International Classes
005